updated on September 6, 2024
September 12 | ||||||||
09:00 - 10:30 Nanomedicine: Successful Stories WS.I.1 - TT.V.J |
||||||||
Chairs: Giovanni TOSI, University of Modena and Reggio Emilia & Marzia BEDONI, Don Gnocchi Foundation | ||||||||
Research in the field of nanomedicine is continuously advancing; however, to bring real solutions into clinical practice, it is essential to align research closely with regulatory considerations, technology transfer, and ultimately, the marketing of products. In this session, international experts will explore some of the most recent and successful developments in nanomedicine research, emphasizing the significant impact that nano-products can have on clinical settings | ||||||||
WS.I.1.1 TT.V.J.1 |
Alexandre CECCALDI ETPN Current and Emerging Nanomedicine Innovations: Success Stories from the European Frontlines |
|||||||
WS.I.1.2 TT.V.J.2 |
Lorena DIEGUEZ International Iberian Nanotechnology Laboratory (INL) Nano-medical devices for liquid biopsy: our tech transfer journey |
|||||||
WS.I.1.3 TT.V.J.3 |
Francesca RE University of Milano Bicocca Patient-derived Glioblastoma Stem Cell Secretome Modulates Blood-Brain Barrier Permeability via RAGE-Dependent Signaling Pathway |
|||||||
11:30 - 13:00 Nanomedicine: Progresses in Nanomedicine WS.I.2 - TT.VI.K |
||||||||
Chairs: Giovanni TOSI, University of Modena and Reggio Emilia & Marzia BEDONI, Don Gnocchi Foundation | ||||||||
In this session, recent progress in nanomedicine academic research will be presented. From the initial conceptualization of nanomedicine design to the final efficacy tests, speakers will discuss the crucial step of deeply analyzing the interaction between the nano-product and the biological environment. During this session, experts will highlight the tight connection between the biological response to nano-products and their design, emphasizing how this relationship influences the effectiveness and safety of nanomedicine applications. | ||||||||
WS.I.2.1 TT.VI.K.1 |
Fabiana QUAGLIA University of Naples Italian National Center for Gene Therapy |
|||||||
WS.I.2.2 TT.VI.K.2 |
Valentina CAUDA Polytechnic University of Turin Rational Design of nanoparticles mimicking extracellular vesicles |
|||||||
WS.I.2.3 TT.VI.K.3 |
Francesca RODÀ University of Modena and Reggio Emilia & Don Gnocchi Foundation mRNA-LNP Ex Vivo Interactions with Human Whole Blood |
|||||||
14:00 - 15:30 Nanomedicine: Innovation WS.I.3 - TT.VII.K |
||||||||
Chairs: Giovanni TOSI, University of Modena and Reggio Emilia & Marzia BEDONI, Fondazione Don Gnocchi | ||||||||
In this session, we will explore groundbreaking advancements in technology that are revolutionizing the healthcare sector. This session will cover fundamental topics that are crucial for the progression of nanomedicine, showcasing the latest developments and key applications in treating diseases that have been notoriously difficult to manage. Speakers and experts delve into how nanotechnology is paving the way for innovative therapeutic approaches, offering new hope for conditions that have long challenged traditional medicine, shaping the future of healthcare and the role of nanomedicine in transforming patient outcomes. | ||||||||
WS.I.3.1 TT.VII.K.1 | Sabrina CUOGHI University of Modena and Reggio Emilia Microfluidic and enzyme replacement therapy: PLGA Nanoparticles towards the development of new versatile therapeutic solutions |
|||||||
WS.I.3.2 TT.VII.K.2 | Carlotta MARIANECCI Sapienza University of Rome Surfactant based nanobubbles: a combined strategy to enhance brain delivery |
|||||||
WS.I.3.3 TT.VII.K.3 | Luigi CALZOLAI ISPRA, JRC European Community Advanced Characterization of Lipid-RNA therapeutics |
|||||||
Back to Overview | Go to Plan 12 September | ||